Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flurbiprofen at night

E C Huskisson, P J Scott, S Boyle

    Current Medical Research and Opinion
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Single doses of flurbiprofen at night effectively reduced pain and morning stiffness in rheumatoid arthritis patients. Higher doses (150 mg) showed superiority over placebo but not over lower doses (100 mg).

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    ERO1A levels are a prognostic indicator in EGFR mutated non small cell lung cancer.

    NPJ precision oncology·2024
    Same author

    Four new anti-inflammatory drugs responses and variations.

    The Medical journal of Malaysia·2022
    Same author

    Predictors of antidepressant use in the English population: analysis of the Adult Psychiatric Morbidity Survey.

    Irish journal of psychological medicine·2020
    Same author

    Process evaluation of a cluster-randomised controlled trial of multi-component weight management programme in adults with intellectual disabilities and obesity.

    Journal of intellectual disability research : JIDR·2018
    Same author

    Congenital disorders in South Africa: A review of Child Healthcare Problem Identification Programme (Child PIP) mortality data, 2005 - 2017.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2018
    Same author

    Legionella longbeachae pneumonia as a complication of alemtuzumab therapy.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2017
    Same journal

    Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Jordan: epidemiology, trends, determinants, and clinical outcomes.

    Current medical research and opinion·2026
    Same journal

    RSV disease and vaccination knowledge, attitudes, and practices among US adults: a 2024-2025 RSV season survey.

    Current medical research and opinion·2026
    Same journal

    Clinical and healthcare resource utilization outcomes following revision knee arthroplasty with and without a gradually reducing radius revision knee system.

    Current medical research and opinion·2026
    Same journal

    Medication adherence measurement methods and their reported relationship with medication safety outcomes: a scoping review.

    Current medical research and opinion·2026
    Same journal

    BMI response to dapagliflozin with or without semaglutide across obesity classes: a real-world observational study conducted in Saudi Arabia.

    Current medical research and opinion·2026
    Same journal

    Comparative efficacy of tislelizumab + FOLFOX or CAPOX for gastric/gastroesophageal junction adenocarcinoma: an exploratory matching-adjusted indirect comparison.

    Current medical research and opinion·2026
    See all related articles

    Area of Science:

    • Rheumatology
    • Pharmacology
    • Clinical Trials

    Background:

    • Rheumatoid arthritis (RA) is a chronic inflammatory disease causing pain, stiffness, and sleep disturbance.
    • Effective management of nocturnal symptoms in RA is crucial for patient well-being.

    Purpose of the Study:

    • To evaluate the efficacy of single nighttime doses of flurbiprofen in managing nocturnal pain, morning stiffness, and sleep disturbance in active RA patients.
    • To compare the effects of different flurbiprofen dosages (100 mg vs. 150 mg) against a placebo.

    Main Methods:

    • Three randomized, double-blind, crossover trials were conducted.
    • Patients with active rheumatoid arthritis received single nighttime doses of flurbiprofen (100 mg or 150 mg) or placebo.
    • Outcomes assessed included nocturnal pain, duration of morning stiffness, and sleep disturbance.

    Related Experiment Videos

    Main Results:

    • Flurbiprofen (150 mg) demonstrated superior efficacy compared to placebo in alleviating nocturnal symptoms.
    • No significant difference in clinical effectiveness was observed between flurbiprofen 150 mg and 100 mg.
    • While serum drug levels were higher with the 150 mg dose, they did not correlate with improved clinical outcomes.

    Conclusions:

    • Single nighttime doses of flurbiprofen are effective for managing nocturnal symptoms in rheumatoid arthritis.
    • A 150 mg dose offers no additional clinical benefit over a 100 mg dose for these symptoms.
    • Further research may be needed to understand the dose-response relationship and optimal dosing strategies.